학술논문

Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer
Document Type
Article
Source
In: Targeted Oncology. (Targeted Oncology, 1 June 2016, 11(3):317-327)
Subject
Language
English
ISSN
1776260X
17762596